Martin Shkreli fired from CEO post at KaloBios Pharmaceuticals

Embattled health care executive Martin Shkreli has been terminated as the CEO of KaloBios Pharmaceuticals, CNBC reports. He also resigned from the company's board of directors.

Shkreli, known for drastically hiking up drug prices, pleaded not guilty Thursday on charges of securities fraud and conspiracy. One day later, he resigned from his other CEO position, at Turing Pharmaceuticals.

In his first interview since the arrest, Shkreli, 32, told The Wall Street Journal that his big public persona and his drug hikes put a target on his back.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

"'Trying to find anything we could to stop him,' was the attitude of the government,” Shkreli said. "Beating the person up and then trying to find the merits to make up for it — I would have hoped the government wouldn't take that kind of approach."